Only a pawn in their game: Orphan drug tax credit on the chopping block again under Dem spending bill

Buried about 1,600 pages into the version of the Build Back Better Act released yesterday afternoon is a pronounced tweak to the orphan drug tax credit that would sharply curtail which clinical testing expenses qualify for the credit.

The change comes amid a growing furor over blockbuster drugs racking up...

Click to view original post